AP
MBII

Alydar Partners’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Alydar Partners’s Portfolio MBII Stock Details MBII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-70,000
Closed -$813K – 142
2014
Q2 		$813K Buy
+70,000
New +$793K 0.07% 95

Other funds holding MBII

WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
AWMDMG
Austin W. Marxe & David M. Greenhouse New York $733M AUM 21.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return
OIM
Orca Investment Management Roseburg, Oregon $118M AUM 36.88% 1-Year Est. Return

Alydar Partners's MBII Position: Q3 2014 in Review

Alydar Partners sold out of Marrone Bio Innovations, Inc. (MBII) in Q3 2014, closing a stake of 70,000 shares — an estimated $813K sold.

Alydar Partners first reported a position in MBII in Q2 2014 and held it in 1 quarter. The position peaked at $813K in Q2 2014. 49 funds tracked by Wall St. Rank hold MBII as of Q3 2014.

  • Alydar Partners reported no remaining Marrone Bio Innovations, Inc. position as of Q3 2014 after selling out during the quarter.
  • Alydar Partners sold 70,000 Marrone Bio Innovations, Inc. shares in Q3 2014, an estimated $813K.
  • Alydar Partners first reported a position in Marrone Bio Innovations, Inc. in Q2 2014 and held it in 1 quarter.
  • Alydar Partners's Marrone Bio Innovations, Inc. position peaked at $813K in Q2 2014.
  • 49 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q3 2014.

Based on Alydar Partners's 13F filing for Q3 2014, filed 14 Nov 2014.